共 13 条
[1]
[2]
[3]
DPP-4 (CD26) inhibitor alogliptin inhibits TLR4-mediated ERK activation and ERK-dependent MMP-1 expression by U937 histiocytes[J] Nga N. Ta;Yanchun Li;Corinne A. Schuyler;Maria F. Lopes-Virella;Yan Huang Atherosclerosis 2010,
[4]
Future Role for Selective Phospholipase A 2 Inhibitors in the Prevention of Atherosclerotic Cardiovascular Disease[J] Robert S. Rosenson Cardiovascular Drugs and Therapy 2009,
[5]
Molecular mechanisms of irbesartan suppressing atherosclerosis in high cholesterol-diet apolipoprotein E knock-out mice[J] Rui Yao;Xiang Cheng;Yong Chen;Jiang-Jiao Xie;Xian Yu;Meng-Yang Liao;Ying-Jun Ding;Ting-Ting Tang;Yu-Hua Liao International Journal of Cardiology 2008,
[6]
Development of Rho-kinase inhibitors for cardiovascular medicine[J] Hiroaki Shimokawa;Mamunur Rashid Trends in Pharmacological Sciences 2007,
[7]
Effects of Anti‐TNF‐α Treatment on Lipid Profile in Patients with Active Rheumatoid Arthritis[J] BRUNO SERIOLO;SABRINA PAOLINO;ALBERTO SULLI;DANIELA FASCIOLO;MAURIZIO CUTOLO Annals of the New York Academy of Sciences 2006,
[8]
Atherosclerosis as Inflammation[J] Philip S. Mullenix;Charles A. Andersen;Benjamin W. Starnes Annals of Vascular Surgery 2005,
[9]
Inflammation in Atherosclerosis and Diabetes Mellitus[J] Jorge Plutzky Reviews in Endocrine and Metabolic Disorders 2004,
[10]
C-reactive protein: From innocent bystander to pivotal mediator of atherosclerosis[J] Carlos A. Labarrere;Gary P. Zaloga The American Journal of Medicine 2004,